MRI for early detection of breast cancer spread
Part of Cancer, Skin clinical trials.
This trial is testing a new way to use MRI scans to find breast cancer that has spread to other parts of the body early. It is for people who have had aggressive breast cancer (HER2 positive or triple negative) and finished treatment with surgery, but still have a higher risk of the cancer coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had breast cancer that was stage II or III and was either HER2 positive or triple negative.
- You had surgery, and if you had chemotherapy before surgery, some cancer was still found after surgery.
- Your staging scans around the time of surgery showed no signs of cancer spreading to other organs.
- You are 75 years old or younger.
- You are in good general health (able to do daily activities without needing help) and have no other active cancers.
- You are willing and able to travel to the study center for follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks the brain using MRI in people with breast cancer that has spread outside the breast or can’t be fully removed. The goal is to screen for brain involvement and see how MRI findings fit with treatment timing, when it’s safe to do so.
This trial checks whether taking screening brain MRI scans in people with stage IV breast cancer helps find brain involvement earlier. It may help guide treatment decisions for those who would otherwise only get brain imaging after symptoms start.
This study is testing a new, more detailed whole-body MRI scan to see how well it can take pictures of the body in people with certain cancers or genetic conditions that increase cancer risk. The goal is to improve early detection and monitoring.
This trial studies whether a special MRI scan can better predict whether early cervical cancer has spread into tiny lymph and blood vessels (lymphovascular space invasion) before surgery. If it works, it may help doctors plan the best treatment after surgery.
This study uses a special type of MRI called diffusion-weighted imaging to help diagnose breast cancer and check on it after treatment. It is for women who have a breast lump or whose breast cancer has returned after chemotherapy or radiation.
This study tests advanced MRI imaging techniques to better diagnose breast cancer and evaluate treatment response. If you have a suspicious breast lesion, this trial may help doctors see it more clearly before biopsy or surgery.
Hear when a new HER2-positive Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.